Impact of the COVID-19 pandemic on incidence, time of diagnosis and delivery of healthcare among paediatric oncology patients in Germany in 2020: Evidence from the German Childhood Cancer Registry and a qualitative survey.

Impact of the COVID-19 pandemic on incidence, time of diagnosis and delivery of healthcare among paediatric oncology patients in Germany in 2020: Evidence from the German Childhood Cancer Registry and a qualitative survey.
复制标题

DOI:
10.1016/j.lanepe.2021.100188
复制
发表时间:
2021-10
期刊:
The Lancet regional health. Europe
影响因子:
--
通讯作者:
Eichinger M
Eichinger M
中科院分区:
其他
文献类型:
--
作者:
Erdmann F;Wellbrock M;Trübenbach C;Spix C;Schrappe M;Schüz J;Grabow D;Eichinger M

文献摘要

参考文献

被引文献

相似文献

COVID-19大流行对癌症治疗和及时诊断的间接影响日益受到关注。我们调查了2019冠状病毒病大流行对2020年德国儿科肿瘤患者发病率、诊断时间和医疗服务提供的影响。我们使用德国儿童癌症登记处的数据分析了2020年德国0至17岁儿童诊断的儿科癌症病例。将2020年的绝对数量和年龄标准化发病率(ASR)与前五年(2015-2019年)进行比较。此外,我们进行了一项带有开放式问题的调查,收集了对COVID-19大流行期间儿科肿瘤患者诊断过程和医疗保健服务的看法。与前五年相比,2020年每个月新诊断的儿科癌症患者数量更多或相似。与2015-2019年相比,2020年估计的asr总体和各诊断组的发病率均显着增加。定性调查结果显示,在2019冠状病毒病大流行期间,诊断流程、诊断及时性和提供治疗几乎没有受到影响。然而,在封锁期间,心理社会支持护理和非紧急预约大大减少。我们没有发现COVID-19大流行对德国癌症儿童的诊断和医疗服务产生严重不良影响的迹象。发病率增加的根本原因仍然是推测性的。对发病率模式的持续密切监测可能揭示目前发病率增加的根本原因,并有助于了解疾病的病因。没有一个
The indirect impact of the COVID-19 pandemic on cancer care and timely diagnosis is of increasing concern. We investigated the impact of the COVID-19 pandemic on incidence, time of diagnosis and delivery of healthcare among paediatric oncology patients in Germany in 2020. We analysed incident paediatric cancer cases diagnosed in 0- to 17-year olds in Germany in 2020 using data of the German Childhood Cancer Registry. Absolute numbers and age-standardised incidence rates (ASR) in 2020 were compared to the previous five years (2015–2019). Moreover, we conducted a survey with open-ended questions, gathering perceptions of the diagnostic process and healthcare delivery for paediatric oncology patients during the COVID-19 pandemic. More or similar numbers of paediatric cancer patients were newly diagnosed each month throughout 2020 in comparison to the previous five years. The estimated ASRs showed markedly higher incidence rates, overall and across diagnostic groups, in 2020 compared to 2015-2019. Results from the qualitative survey indicated that diagnostic processes, timeliness of diagnosis, and delivery of treatment were hardly affected during the COVID-19 pandemic. However, psychosocial supportive care and non-urgent appointments were considerably reduced during the lockdown periods. We found no indications of severe adverse effects of the COVID-19 pandemic on diagnosis and delivery of healthcare among children with cancer in Germany. The underlying reasons of the increase in incidence rates remain speculative. Continued close monitoring of incidence patterns may shed light on the underlying reasons of the present increase and contribute to understanding disease aetiology. None
DOI: 10.1002/cncr.33075
发表时间: 2020-07-10
期刊: CANCER
影响因子: 6.2
作者:
Saab, Raya;Obeid, Anas;Jeha, Sima
通讯作者: Jeha, Sima
DOI: 10.1002/cncr.20910
发表时间: 2005-04-01
期刊: CANCER
影响因子: 6.2
作者:
Steliarova-Foucher, E;Stiller, C;Kaatsch, P
通讯作者: Kaatsch, P
DOI: 10.1016/s0140-6736(17)33326-3
发表时间: 2018-03-17
期刊: Lancet (London, England)
影响因子: --
作者:
Allemani C;Matsuda T;Di Carlo V;Harewood R;Matz M;Nikšić M;Bonaventure A;Valkov M;Johnson CJ;Estève J;Ogunbiyi OJ;Azevedo E Silva G;Chen WQ;Eser S;Engholm G;Stiller CA;Monnereau A;Woods RR;Visser O;Lim GH;Aitken J;Weir HK;Coleman MP;CONCORD Working Group
通讯作者: CONCORD Working Group
DOI: 10.1016/s1470-2045(13)70548-5
发表时间: 2014-01-01
期刊: LANCET ONCOLOGY
影响因子: 51.1
作者:
Gatta, Gemma;Botta, Laura;Peris-Bonet, Rafael
通讯作者: Peris-Bonet, Rafael
DOI: 10.1016/s1470-2045(13)70010-x
发表时间: 2013-03-01
期刊: LANCET ONCOLOGY
影响因子: 51.1
作者:
Pritchard-Jones, Kathy;Pieters, Rob;Steliarova-Foucher, Eva
通讯作者: Steliarova-Foucher, Eva